165 related articles for article (PubMed ID: 29203794)
1. Behavioral impairment in SHATI/NAT8L knockout mice via dysfunction of myelination development.
Sumi K; Uno K; Noike H; Tomohiro T; Hatanaka Y; Furukawa-Hibi Y; Nabeshima T; Miyamoto Y; Nitta A
Sci Rep; 2017 Dec; 7(1):16872. PubMed ID: 29203794
[TBL] [Abstract][Full Text] [Related]
2. Deletion of SHATI/NAT8L decreases the N-acetylaspartate content in the brain and induces behavioral deficits, which can be ameliorated by administering N-acetylaspartate.
Toriumi K; Mamiya T; Song Z; Honjo T; Watanabe H; Tanaka J; Kondo M; Mouri A; Kim HC; Nitta A; Fukushima T; Nabeshima T
Eur Neuropsychopharmacol; 2015 Nov; 25(11):2108-17. PubMed ID: 26361739
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of Shati/Nat8l overexpression in the medial prefrontal cortex on methamphetamine-induced conditioned place preference in mice.
Haddar M; Uno K; Azuma K; Muramatsu SI; Nitta A
Addict Biol; 2020 May; 25(3):e12749. PubMed ID: 30950164
[TBL] [Abstract][Full Text] [Related]
4. Do reductions in brain N-acetylaspartate levels contribute to the etiology of some neuropsychiatric disorders?
Ariyannur PS; Arun P; Barry ES; Andrews-Shigaki B; Bosomtwi A; Tang H; Selwyn R; Grunberg NE; Moffett JR; Namboodiri AM
J Neurosci Res; 2013 Jul; 91(7):934-42. PubMed ID: 23633398
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of Shati/Nat8l, an N-acetyltransferase, in the nucleus accumbens attenuates the response to methamphetamine via activation of group II mGluRs in mice.
Miyamoto Y; Ishikawa Y; Iegaki N; Sumi K; Fu K; Sato K; Furukawa-Hibi Y; Muramatsu S; Nabeshima T; Uno K; Nitta A
Int J Neuropsychopharmacol; 2014 Aug; 17(8):1283-94. PubMed ID: 24559655
[TBL] [Abstract][Full Text] [Related]
6. Striatal N-Acetylaspartate Synthetase Shati/Nat8l Regulates Depression-Like Behaviors via mGluR3-Mediated Serotonergic Suppression in Mice.
Miyamoto Y; Iegaki N; Fu K; Ishikawa Y; Sumi K; Azuma S; Uno K; Muramatsu SI; Nitta A
Int J Neuropsychopharmacol; 2017 Dec; 20(12):1027-1035. PubMed ID: 29020418
[TBL] [Abstract][Full Text] [Related]
7. Induction of neuronal axon outgrowth by Shati/Nat8l by energy metabolism in mice cultured neurons.
Sumi K; Uno K; Matsumura S; Miyamoto Y; Furukawa-Hibi Y; Muramatsu S; Nabeshima T; Nitta A
Neuroreport; 2015 Sep; 26(13):740-6. PubMed ID: 26164607
[TBL] [Abstract][Full Text] [Related]
8. Shati/Nat8l knockout mice show behavioral deficits ameliorated by atomoxetine and methylphenidate.
Toriumi K; Tanaka J; Mamiya T; Alkam T; Kim HC; Nitta A; Nabeshima T
Behav Brain Res; 2018 Feb; 339():207-214. PubMed ID: 29203337
[TBL] [Abstract][Full Text] [Related]
9. Impairment of cognitive function induced by Shati/Nat8l overexpression in the prefrontal cortex of mice.
Haddar M; Azuma K; Izuo N; Kyosuke U; Asano T; Muramatsu SI; Nitta A
Behav Brain Res; 2021 Jan; 397():112938. PubMed ID: 32998043
[TBL] [Abstract][Full Text] [Related]
10. Methamphetamine induces Shati/Nat8L expression in the mouse nucleus accumbens via CREB- and dopamine D1 receptor-dependent mechanism.
Uno K; Miyazaki T; Sodeyama K; Miyamoto Y; Nitta A
PLoS One; 2017; 12(3):e0174196. PubMed ID: 28319198
[TBL] [Abstract][Full Text] [Related]
11. N-Acetyl Transferase, Shati/Nat8l, in the Dorsal Hippocampus Suppresses Aging-induced Impairment of Cognitive Function in Mice.
Miyanishi H; Kitazawa A; Izuo N; Muramatsu SI; Nitta A
Neurochem Res; 2022 Sep; 47(9):2703-2714. PubMed ID: 35428956
[TBL] [Abstract][Full Text] [Related]
12. Absence of SHATI/Nat8l reduces social interaction in mice.
Furukawa-Hibi Y; Nitta A; Fukumitsu H; Somiya H; Toriumi K; Furukawa S; Nabeshima T; Yamada K
Neurosci Lett; 2012 Sep; 526(2):79-84. PubMed ID: 22940080
[TBL] [Abstract][Full Text] [Related]
13. Shati/Nat8l deficiency disrupts adult neurogenesis and causes attentional impairment through dopaminergic neuronal dysfunction in the dentate gyrus.
Wulaer B; Kunisawa K; Hada K; Jaya Suento W; Kubota H; Iida T; Kosuge A; Nagai T; Yamada K; Nitta A; Yamamoto Y; Saito K; Mouri A; Nabeshima T
J Neurochem; 2021 May; 157(3):642-655. PubMed ID: 32275776
[TBL] [Abstract][Full Text] [Related]
14. The neuronal metabolite NAA regulates histone H3 methylation in oligodendrocytes and myelin lipid composition.
Singhal NK; Huang H; Li S; Clements R; Gadd J; Daniels A; Kooijman EE; Bannerman P; Burns T; Guo F; Pleasure D; Freeman E; Shriver L; McDonough J
Exp Brain Res; 2017 Jan; 235(1):279-292. PubMed ID: 27709268
[TBL] [Abstract][Full Text] [Related]
15. Shati/Nat8l Overexpression Improves Cognitive Decline by Upregulating Neuronal Trophic Factor in Alzheimer's Disease Model Mice.
Chino K; Izuo N; Noike H; Uno K; Kuboyama T; Tohda C; Muramatsu SI; Nitta A
Neurochem Res; 2022 Sep; 47(9):2805-2814. PubMed ID: 35759136
[TBL] [Abstract][Full Text] [Related]
16. Vulnerability to depressive behavior induced by overexpression of striatal Shati/Nat8l via the serotonergic neuronal pathway in mice.
Uno K; Miyanishi H; Sodeyama K; Fujiwara T; Miyazaki T; Muramatsu SI; Nitta A
Behav Brain Res; 2019 Dec; 376():112227. PubMed ID: 31520691
[TBL] [Abstract][Full Text] [Related]
17. [The role of a molecule associated with drug dependence, shati/nat8l].
Miyamoto Y; Saika E; Hori E; Iegaki N; Sumi K; Nabeshima T; Muramatsu S; Nishijo H; Uno K; Nitta A
Nihon Shinkei Seishin Yakurigaku Zasshi; 2013 Aug; 33(4):167-73. PubMed ID: 25069253
[TBL] [Abstract][Full Text] [Related]
18. Decreased DNA Methylation in the Shati/Nat8l Promoter in Both Patients with Schizophrenia and a Methamphetamine-Induced Murine Model of Schizophrenia-Like Phenotype.
Uno K; Kikuchi Y; Iwata M; Uehara T; Matsuoka T; Sumiyoshi T; Okamoto Y; Jinno H; Takada T; Furukawa-Hibi Y; Nabeshima T; Miyamoto Y; Nitta A
PLoS One; 2016; 11(6):e0157959. PubMed ID: 27348532
[TBL] [Abstract][Full Text] [Related]
19. Deletion of SHATI/NAT8L increases dopamine D1 receptor on the cell surface in the nucleus accumbens, accelerating methamphetamine dependence.
Toriumi K; Kondo M; Nagai T; Hashimoto R; Ohi K; Song Z; Tanaka J; Mouri A; Koseki T; Yamamori H; Furukawa-Hibi Y; Mamiya T; Fukushima T; Takeda M; Nitta A; Yamada K; Nabeshima T
Int J Neuropsychopharmacol; 2014 Mar; 17(3):443-53. PubMed ID: 24246274
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
